Clinical Trials in Baltimore

Showing 11981-12000 of 20,142 trials

Navigation Services to Avoid Rehospitalization (NavSTAR)

NCT02599818

This study will examine the clinical effectiveness and health economic profile of services to link hospital patients with substance use disorders to addiction treatment, promote their medical stabilization, and reduce hospital re-admissions.

Opioid-use DisorderCocaine Use DisorderAlcohol Use Disorder

Friends Research Institute, Inc.400 participantsStarted Mar 2016

Baltimore, Maryland, United States

COMPLETEDPhase 1< 1 mile

Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer

NCT02605915

This is a Phase Ib, open-label, two-stage study with two active regimens in each stage designed to evaluate the safety and tolerability of combination treatment with atezolizumab, trastuzumab, and pertuzumab (with and without docetaxel) or atezolizumab and trastuzumab emtansine in participants with human epidermal growth factor receptor 2 (HER2) positive metastatic breast cancer (MBC) and locally advanced early breast cancer (EBC), and atezolizumab with doxorubicin and cyclophosphamide in HER2-negative breast cancer.

HER2-Positive Metastatic Breast CancerHER2-Negative Metastatic Breast CancerLocally Advanced or Early Breast Cancer

Hoffmann-La Roche98 participantsStarted Dec 2015

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Joliet, Illinois, United States +17 more locations

Navigation Services to Avoid Rehospitalization (NavSTAR)

Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer

Find Trials by Condition in Baltimore

Evaluate the Safety Pharmacokinetics of a Human Monoclonal Antibody S315 Against Diphtheria Toxin in Healthy Subjects

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises

Nutrition and Aerobic Exercise in Chronic Stroke

DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer

Evaluation of the Health and Economic Consequences of Kentucky's Section 1115 Demonstration Waiver

Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas

Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation

Topical Raplixa for Surgical Bleeding in Children

ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain

A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)

Endotracheal Intubation Among the Critically Ill: HEMAIR Pilot Study

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants

Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients

First-in-Human Study of MS201408-0005A as Single Agent and in Combinations

Treatment for Teens With Alcohol Abuse and Depression

Drug Interactions Between Morphine and Orally or IV Administered Acetaminophen